Phar Vision Advisers, LLC Avita Medical, Inc. Transaction History
Phar Vision Advisers, LLC
- $69.6 Billion
- Q2 2025
A detailed history of Phar Vision Advisers, LLC transactions in Avita Medical, Inc. stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 16,508 shares of RCEL stock, worth $92,609. This represents 0.13% of its overall portfolio holdings.
Number of Shares
16,508Holding current value
$92,609% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding RCEL
# of Institutions
85Shares Held
7.6MCall Options Held
46.5KPut Options Held
18.5K-
Black Rock Inc. New York, NY1.78MShares$10 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$8.14 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA618KShares$3.47 Million0.0% of portfolio
-
State Street Corp Boston, MA529KShares$2.97 Million0.0% of portfolio
-
Ubs Group Ag410KShares$2.3 Million0.0% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $140M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...